Skip to content

Clinical trials

Terminated Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Terminated Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20065
20072
20086
20093
20107
20116
20122
20137
20144
20154
20167
20172
20185
20198
20215
20225
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion12
Novartis Pharmaceuticals7
Pfizer6
United Therapeutics6
Aerovate Therapeutics2
Aires Pharmaceuticals, Inc.2
Biogen2
Complexa, Inc.2
Idorsia Pharmaceuticals Ltd.2
Laval University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension84
Hypertension, Pulmonary32
Hypertension6
Familial Primary Pulmonary Hypertension5
Cardiovascular Diseases3
Connective Tissue Diseases3
Eisenmenger Complex3
Lung Diseases3
Vascular Diseases3
Anemia, Sickle Cell2

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.